Showing 121-130 of 3286 results for "".
- Merz Aesthetics Announces FDA Clearance of Ultherapy PRIME for Knee Skin Laxityhttps://modernaesthetics.com/news/merz-aesthetics-announces-fda-clearance-of-ultherapy-prime-for-knee-skin-laxity/2488072/The US Food and Drug Administration (FDA) has cleared Ultherapy PRIME (Merz Aesthetics) to improve the appearance of skin laxity on the knees, according to an announcement from the company. Merz Aesthetics said the clearance makes Ultherapy PRIME the first energy-based aesthetic device wit
- Allergan Aesthetics Updates Practice Loyalty Program With New Growth Benefitshttps://modernaesthetics.com/news/allergan-aesthetics-updates-practice-loyalty-program-with-new-growth-benefits/2488065/Allergan Aesthetics, an AbbVie company, announced updates to its Allergan Partner Privileges (APP) customer portfolio loyalty program for aesthetics practices, with changes focused on pricing and benefit transparency as well as rewards tied to portfolio growth.
- Persistent Hyperpigmentation Reported After Coretox Injectionshttps://modernaesthetics.com/news/persistent-hyperpigmentation-reported-after-coretox-injections/2488066/Persistent hyperpigmentation may represent a rare adverse event following Coretox botulinum toxin type A injections, according to a 3-patient case series published August 6 in Plastic and Reconstructive Surgery – Global Open
- FDA Accepts BOTOX Cosmetic Application for Masseter Muscle Prominencehttps://modernaesthetics.com/news/fda-accepts-botox-cosmetic-application-for-masseter-muscle-prominence/2488051/The US Food and Drug Administration (FDA) has accepted Allergan Aesthetics’ supplemental Biologics License Application (sBLA) for BOTOX Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of marked to very marked masseter muscle prominence
- ASDS Launches Financial, Technology Retreat for Dermatologistshttps://modernaesthetics.com/news/asds-launches-financial-technology-retreat-for-dermatologists/2488019/The American Society for Dermatologic Surgery (ASDS) is broadening its educational portfolio with the debut of $kin in the Game, a new financial and technology literacy retreat designed exclusively for dermatologists. The two-day program, developed in collaboration with Wilmington Trust,
- Study Validates Rapid Screening Tool for Plastic Surgery Meta-analyseshttps://modernaesthetics.com/news/study-validates-rapid-screening-tool-for-plastic-surgery-meta-analyses/2488009/A newly published study suggests that a simple three-question screening tool may help clinicians quickly identify low-quality meta-analyses without relying on lengthy methodological assessments. In a study published in the
- Fractional CO₂ Laser-Assisted Methotrexate Rivals 5-FU in Stable Vitiligohttps://modernaesthetics.com/news/fractional-co-laser-assisted-methotrexate-rivals-5-fu-in-stable-vitiligo/2487990/Topical methotrexate (MTX) delivered through fractional CO₂ laser (FCL) demonstrated efficacy and safety comparable to laser-assisted 5-fluorouracil (5-FU) for stable, nonsegmental vitiligo, according to a study published in Derm
- Meta-Analysis: Comparable Overall Outcomes With Lasers and Chemical Peels for Skin Rejuvenationhttps://modernaesthetics.com/news/meta-analysis-vcomparable-overall-outcomes-with-lasers-and-chemical-peels-for-skin-rejuvenation/2487992/A systematic review and meta-analysis published in Plastic and Reconstructive Surgery found that laser resurfacing and chemical peeling provide comparable overall efficacy for skin rejuvenation, although each modality demon
- Secondary Liquid Rhinoplasty Achieves 90%+ Patient Satisfaction: Studyhttps://modernaesthetics.com/news/secondary-liquid-rhinoplasty-achieves-90-patient-satisfaction-study/2487989/Secondary liquid rhinoplasty using hyaluronic acid dermal fillers may offer a safe and effective option for correcting postsurgical nasal contour irregularities, according to a large retrospective study published in the Aesthetic
- Allergan Aesthetics Announces Return of JUVÉDERM® Day for 2026https://modernaesthetics.com/news/allergan-aesthetics-announces-return-of-juvederm-day-for-2026/2487978/Allergan Aesthetics, an AbbVie company, has announced that JUVÉDERM® Day will return to the United States on August 19, 2026. The annual event will coincide with the 20th anniversary of the brand's first US Food and Drug Administration (FDA) approval and will feature promotional offers for member